---
schema_version: "secwatch.filing_event.v1"
accession: "0001477449-25-000096"
form_type: "8-K"
ticker: "TDOC"
cik: "0001477449"
company_name: "Teladoc Health, Inc."
filed_at: "2025-07-29T23:59:59+00:00"
generated_at: "2026-05-17T23:38:01.165610+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Teladoc Q2 revenue $631.9M (-2% YoY); adjusted EBITDA $69.3M (-23%); retires $550.6M convertible notes

## Summary
- Net loss of $32.7M ($0.19 per share), improved from $837.7M loss in Q2 2024 which included $790M goodwill impairment.
- Integrated Care segment revenue $391.5M (+4% YoY); BetterHelp revenue $240.4M (-9% YoY).
- Paid $550.6M cash to retire convertible notes; entered a five-year $300M secured revolving credit facility on July 17.
- Full-year 2025 revenue guidance $2,501–$2,548M; adjusted EBITDA $263–$294M; Q3 revenue guidance $614–$636M.
- Free cash flow $61.2M in Q2 vs. $60.9M in Q2 2024; Capex $30.2M.

## SEC filing metadata
- accession: 0001477449-25-000096
- form_type: 8-K
- ticker: TDOC
- cik: 0001477449
- company_name: Teladoc Health, Inc.
- filed_at: 2025-07-29T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1477449/000147744925000096/0001477449-25-000096-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1477449/000147744925000096/tdoc-20250729.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477449-25-000096
- JSON: https://secwatch.observer/filing/0001477449-25-000096.json
- Plain text: https://secwatch.observer/filing/0001477449-25-000096.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.